AstraZeneca | AZN - Trade Debtors

Stock Price
13,692.00
Daily Change
-208.00 -1.50%
Monthly
-6.87%
Yearly
27.63%
Q2 Forecast
13,721.54

AstraZeneca reported $17.88B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Alcon AG USD 2.54B 596M Dec/2025
Almirall EUR 175.93M 17.87M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
argenx SE USD 1.2B 289.13M Jun/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
Autolus Therapeutics Ltd USD 91.36M 58.83M Sep/2025
Bayer EUR 14.19B 720M Dec/2025
Biogen USD 1.87B 17M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Fresenius EUR 4.08B 18M Sep/2025
Fresenius Medical Care EUR 3.66B 382.33M Dec/2025
Galapagos EUR 199.75M 122.08M Dec/2025
Genmab DKK 1.17B 119M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
GRIFOLS EUR 852M 244.52M Dec/2025
Haleon GBP 2.21B 59M Jun/2025
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.44B 293M Dec/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 12.29B 3.3B Dec/2025
Orion EUR 699.6M 270.4M Mar/2026
Pfizer USD 18.12B 2.02B Sep/2025
Philips EUR 3.8B 266M Dec/2025
Recordati EUR 699.76M 472K Sep/2025
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
UCB EUR 1.97B 54M Dec/2025